Suzhou, China: Pfizer to invest $200 million in CStone shares and license CStone’s late-stage oncology asset sugemalimab (CS1001, PD-L1 antibody) in mainland ChinaCStone to receive...
New Delhi: In a significant escalation of the ongoing conflict, Russia launched an intercontinental ballistic missile (ICBM) from its southern Astrakhan region early Thursday...